FindTrial
Sign In

comparing ultrasound guided infraclavicular block using Dexmedomitidine as adjuvants to Ropivacaine(0.375%) and Levobupivacaine (0.25%) for upper limb surgical interventions.

To compare ultrasound guided infraclavicular block characterstics using dexmedomitidine as adjuvant to ropivacaine and levobupivacaine for upper limb surgical intervention - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062687
Enrollment
80
Registered
2024-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: Infraclavicular block using Dexmedomitidine as adjuvants to Ropivacaine(0.375%) and Levobupivacaine (0.25%): Comparing the effects( Onset andduration of sensory and motor blockageas wel

Sponsors

Armed forces medical college, Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I, II, III, IV 2. Age 18- 60years 3. Patients listed for surgical intervention in upper limb 4. Written informed consent of patient for the study

Exclusion criteria

Exclusion criteria: 1. Age 60 years 2. History of allergy to local anesthetic drugs being used in the block 3. Presence of any neurological deficit in the involved limb 4. Fractures involving clavicle, shoulder region and upper 1/3 rd ofhumerus 5. Local site infection 6. Any structural deformity of the injection site 7. History of coagulopathy or patients using anticoagulants 8. Peripheral vascular disease 9. Block which failed and converted to other Anaesthesia technique

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory and motor blockage as well as analgesiaTimepoint: Onset and duration of sensory and motor blockage as well as analgesia initially, every 3 minutes till the full motor and sensory block is achieved, then postop every hour until 24 hours.—

Secondary

MeasureTime frame
Intraoperative monitoring of vitals (pulse rate, blood pressure, O2saturation and adverse effect if any), duration of analgesia, complications (if any) along with supplemented analgesiaTimepoint: every 15 min intraop then every 30 min for first 90 min then 2 hourly—

Countries

India

Contacts

Public ContactSAURABH SUD

ARMED FORCES MEDICAL COLLEGE

Saurabhsood1975@gmail.com6005709381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026